Skip to main content
Bliss GVS Pharma Limited logo

Bliss GVS Pharma Limited — Investor Relations & Filings

Ticker · BLISSGVS ISIN · INE416D01022 LEI · 335800GXY3YCGGP7KJ45 BSE.NS Manufacturing
Open in API
Filings indexed 1,237 across all filing types
Latest filing 2026-01-27 Capital/Financing Update
Country IN India
Listing BSE.NS BLISSGVS

About Bliss GVS Pharma Limited

https://blissgvs.com/

Bliss GVS Pharma Limited specializes in the development, manufacturing, and marketing of diverse pharmaceutical formulations. The company is a global leader in the production of suppositories and pessaries, maintaining an extensive portfolio within these specialized dosage forms. Its therapeutic focus includes anti-malarials, anti-fungals, anti-bacterials, anti-inflammatories, and gastrointestinal treatments. The organization operates state-of-the-art manufacturing facilities compliant with international quality standards, including WHO-GMP. With a strategic focus on emerging markets, the company distributes its range of prescription and over-the-counter products across Sub-Saharan Africa, Southeast Asia, and Latin America, leveraging a robust supply chain to provide accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015, we would like to inform you that Bliss GVS International PTE Ltd., Singapore, a wholly owned subsidiary of Bliss GVS Pharma Limited, ....
Capital/Financing Update Classification · 95% confidence The document is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the incorporation of a wholly owned subsidiary by Bliss GVS Pharma Limited. It includes details about the subsidiary such as name, share capital, date of incorporation, and ownership structure. The document is addressed to stock exchanges and references SEBI circulars related to disclosure requirements. There are no financial statements or detailed financial performance data. The document is a regulatory announcement about corporate structure changes, specifically the incorporation of a subsidiary, which fits the category of Capital/Financing Update (CAP) as it relates to changes in the company's capital structure and subsidiaries. The document length is under 5,000 characters and is not a report publication announcement or certification. Therefore, the appropriate classification is CAP with high confidence.
2026-01-27 English
Updates
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the incorporation of a wholly owned subsidiary by Bliss GVS Pharma Limited. It includes detailed disclosure information as per SEBI circulars about the subsidiary's name, share capital, industry, and other particulars. There is no financial data, earnings information, or report attached. The document is a regulatory announcement about a corporate action (incorporation of a subsidiary) and is filed with stock exchanges as per regulatory requirements. It fits best under Regulatory Filings (RNS) as it is a general regulatory announcement and does not fall under other specific categories like Capital/Financing Update or M&A Activity since it is about incorporation, not acquisition or merger.
2026-01-27 English
Please find enclosed herewith the certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2025.
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2025. It is issued by the Registrar and Share Transfer Agent and confirms dematerialisation activities and securities handling for the quarter. The document is addressed to stock exchanges and is a compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. It is a regulatory compliance filing related to securities and share transfer regulations. The document length is 3429 characters, which is relatively short and consistent with a certificate or attestation. Therefore, it fits best under Regulatory Filings (RNS) as it is a regulatory compliance certificate and not a financial report or announcement of a report.
2026-01-05 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2025. It is issued by the Registrar and Share Transfer Agent confirming dematerialisation of securities and related compliance. The document is addressed to stock exchanges and the company, and it is a compliance certificate rather than a financial report or announcement of financial results. The document length is 3429 characters, which is relatively short and primarily contains a certification statement. It does not contain financial statements, management discussion, or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS) as it is a regulatory compliance certificate and not a financial report or announcement of a report.
2026-01-05 English
Copy of Newspaper Publication
Proxy Solicitation & Information Statement Classification · 93% confidence The document is not a financial report but rather a formal shareholder notice soliciting votes via postal ballot and remote e-voting, containing the resolution details, voting instructions, timelines, and related regulatory references. It is not declaring results but is providing information to shareholders requesting their vote. This corresponds to a Proxy Solicitation & Information Statement.
2025-12-31 English
Please find enclosed herewith an advertisement published in the Newspaper confirming the dispatch of the Postal Ballot Notice.
Regulatory Filings
2025-12-31 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.